{"id":167783,"date":"2023-12-02T02:41:50","date_gmt":"2023-12-02T07:41:50","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/allogene-therapeutics-announces-participation-in-december-investor-conference\/"},"modified":"2024-08-18T11:47:27","modified_gmt":"2024-08-18T15:47:27","slug":"allogene-therapeutics-announces-participation-in-december-investor-conference","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/allogene-therapeutics-announces-participation-in-december-investor-conference.php","title":{"rendered":"Allogene Therapeutics Announces Participation in December Investor Conference"},"content":{"rendered":"<p><![CDATA[SOUTH SAN FRANCISCO, Calif., Dec.  01, 2023  (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T\u2122) products for cancer, today announced that it will participate in one upcoming investor conference in December.]]><\/p>\n<p>Read the original post:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2023\/12\/01\/2789296\/0\/en\/Allogene-Therapeutics-Announces-Participation-in-December-Investor-Conference.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Allogene Therapeutics Announces Participation in December Investor Conference\">Allogene Therapeutics Announces Participation in December Investor Conference<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read the original post: Allogene Therapeutics Announces Participation in December Investor Conference <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/allogene-therapeutics-announces-participation-in-december-investor-conference.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-167783","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/167783"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=167783"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/167783\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=167783"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=167783"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=167783"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}